UK markets open in 4 hours 13 minutes
NIKKEI 225
38,289.44 -545.66 (-1.41%) HANG SENG
18,550.72 +71.35 (+0.39%) CRUDE OIL
78.09 -0.29 (-0.37%) GOLD FUTURES
2,319.40 -4.80 (-0.21%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,287.73 -716.45 (-1.40%)
AbCellera Biologics Inc. (ABCL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 4.1100 |
| Open | 4.1200 |
| Bid | 4.0300 x 800 |
| Ask | 4.0600 x 800 |
| Day's range | 3.9900 - 4.2800 |
| 52-week range | 3.6200 - 8.0500 |
| Volume | |
| Avg. volume | 1,412,967 |
| Market cap | 1.187B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
AbCellera Biologics (ABCL) delivered earnings and revenue surprises of 12.50% and 11.64%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- GuruFocus.com
AbCellera Biologics Inc (ABCL) Q1 2024 Earnings: Misses Revenue and Net Loss Estimates
Detailed Analysis of Financial Performance and Strategic Initiatives
- Simply Wall St.
Insider Stock Buying Reaches US$1.61m On AbCellera Biologics
Quite a few insiders have dramatically grown their holdings in AbCellera Biologics Inc. ( NASDAQ:ABCL ) over the past...
© 2024 Yahoo. All rights reserved.